PLSM
Pulsenmore Ltd. Ordinary Shares
NASDAQ · Healthcare · Medical - Devices · IL
$2.45
−2.00%Year over year
Reported trailing growth
- Revenue
- +603.3%
- EBITDA
- -87.7%
- EBIT
- -45.2%
- EPS
- -40.3%
- Free cash flow
- -93.1%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +55.8%
- EBITDA
- +61.8%
- EBIT
- +71.1%
- Net income
- +56.7%
- EPS
- +56.7%
- Free cash flow
- +3.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025